Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Non-Current Debt: 2019-2025

Historic Non-Current Debt for Tg Therapeutics (TGTX) over the last 6 years, with Sep 2025 value amounting to $245.3 million.

  • Tg Therapeutics' Non-Current Debt rose 0.48% to $245.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.3 million, marking a year-over-year increase of 0.48%. This contributed to the annual value of $244.4 million for FY2024, which is 144.14% up from last year.
  • Latest data reveals that Tg Therapeutics reported Non-Current Debt of $245.3 million as of Q3 2025, which was up 0.12% from $245.0 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Non-Current Debt ranged from a high of $245.3 million in Q3 2025 and a low of $66.8 million during Q4 2021.
  • Its 3-year average for Non-Current Debt is $165.5 million, with a median of $102.5 million in 2024.
  • Data for Tg Therapeutics' Non-Current Debt shows a peak YoY spiked of 765.58% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Non-Current Debt stood at $66.8 million in 2021, then increased by 6.51% to $71.1 million in 2022, then surged by 40.74% to $100.1 million in 2023, then spiked by 144.14% to $244.4 million in 2024, then climbed by 0.48% to $245.3 million in 2025.
  • Its Non-Current Debt was $245.3 million in Q3 2025, compared to $245.0 million in Q2 2025 and $244.7 million in Q1 2025.